N-((3R)-1-(2,3,6,7-TETRAHYDRO-7-(4-HYDROXY-2-BUTYN-1-YL)-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL-2-14C)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)-3-PIPERIDINYL)ACETAMIDE
UNII YM71J8YOY3
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((3r)-1-(2,3,6,7-tetrahydro-7-(4-hydroxy-2-butyn-1-yl)-3-methyl-1-((4-methyl-2-quinazolinyl-2-14c)methyl)-2,6-dioxo-1h-purin-8-yl)-3-piperidinyl)acetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YM71J8YOY3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1297274-01-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H30N8O4 YPUTXYAMPNLRKZ-LJQANCHMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((3r)-1-(2,3,6,7-tetrahydro-7-(4-hydroxy-2-butyn-1-yl)-3-methyl-1-((4-methyl-2-quinazolinyl-2-14c)methyl)-2,6-dioxo-1h-purin-8-yl)-3-piperidinyl)acetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.